Haishun New Materials Co., Ltd.
海顺新材
300501
Shenzhen Stock Exchange
Key Financials
As of 2026-05-23T00:00:00.000+00:00Announcements
Announcement on the Completion of the Share Reduction Plan by Shareholders
Announcement on the Change of Rights of the Controlling Shareholder and its Concerted Actors Touching 1% Integer Multiple
Announcement on Opening a Special Account for Temporarily Supplementing Working Capital with Raised Funds and Signing Supervision Agreement
Announcement on the resumption of conversion of Haishun convertible bonds
Reminder Announcement on the Disclosure of Q1 Report for 2026
Q1 Report for 2026
Announcement on the Implementation of the 2025 Annual Equity Distribution
Announcement on Adjustment of Conversion Price for Convertible Corporate Bonds
Announcement on the Completion of Non-Transaction Transfer of Reserved Shares in the 2024 Employee Stock Ownership Plan
Announcement on the Suspension of Conversion of Haishun Convertible Bonds during the Equity Distribution Period
Legal opinion letter from Hunan Qiyuan Law Firm regarding the 2025 Annual Shareholders' Meeting of Shanghai Haishun New Pharmaceutical Packaging Materials Co., Ltd.
Resolution announcement of the 2025 Annual Shareholders' Meeting
Announcement on the addition of sources for the conversion of Hai Shun convertible bonds
Reminder Announcement on the 2025 Annual Shareholders' Meeting
Announcement on Opening a Temporary Special Account for Supplementing Working Capital for Raised Funds and Signing a Supervision Agreement
CITIC Securities Co., Ltd. regarding the 2025 annual tracking report of Shanghai Haishun New Pharmaceutical Packaging Materials Co., Ltd.
CITIC Securities Co., Ltd. regarding the 2025 annual continuous supervision regular on-site inspection report of Shanghai Haishun New Pharmaceutical Packaging Materials Co., Ltd.
CITIC Securities Co., Ltd. regarding the summary report of continuous supervision and sponsorship for Shanghai Haishun New Pharmaceutical Packaging Materials Co., Ltd.
Announcement on the allocation of reserved shares for the 2024 employee stock ownership plan
Resolution announcement of the 5th meeting of the 6th Board of Directors
CITIC Securities' report on the continuous supervision training of Shanghai Haishun New Pharmaceutical Packaging Materials Co., Ltd. for the year 2025
Announcement on the Conversion of Convertible Corporate Bonds in the First Quarter of 2026
CITIC Securities Co., Ltd. Verification Opinion on Shanghai Haishun New Pharmaceutical Packaging Materials Co., Ltd.'s Continued Use of Part of Idle Raised Funds for Cash Management
Announcement on Continuing to Use Part of Idle Raised Funds for Cash Management
Announcement on Re-appointing the Company's Audit Firm for 2026
2025 Annual Performance Report of Independent Director (Guo Xun)
2025 Annual Performance Report of Independent Director (Wang Linlin)
2025 Annual Performance Report of Independent Director (Ma Shihong)
Announcement on Holding the 2025 Annual Performance Briefing
CITIC Securities Co., Ltd. Verification Opinion on Shanghai Haishun New Pharmaceutical Packaging Materials Co., Ltd.'s 2025 Annual Internal Control Self-Assessment Report
Shanghai Haishun New Pharmaceutical Packaging Materials Co., Ltd. Internal Control Audit Report
2025 Annual Internal Control Self-Assessment Report
Shanghai Haishun New Pharmaceutical Packaging Materials Co., Ltd. Remuneration Management System for Directors and Senior Management
2026 Remuneration Plan for Directors and Senior Management
Announcement on Applying for a Comprehensive Credit Line for 2026
2025 Annual Performance Report of the Board of Directors' Audit Committee
Announcement on Continuing to Use Part of Idle Own Funds for Cash Management
2025 Annual Report of the General Manager
2025 Annual Report of the Board of Directors
Prompt Announcement on the Disclosure of the Company's 2025 Annual Report
Announcement on Changes in Accounting Policies
Announcement on Accruing Asset Impairment Provisions for the Year 2025
Announcement on the Non-Achievement of Performance Assessment for the 2024 Employee Stock Ownership Plan
Announcement on Depositing Raised Funds in Agreement Deposits
Announcement on the Extension of Some Fund-Raising Investment Projects
CITIC Securities Co., Ltd. Verification Opinion on the Extension of Some Fund-Raising Investment Projects of Shanghai Haishun New Pharmaceutical Packaging Materials Co., Ltd.
CITIC Securities Co., Ltd. Verification Opinion on Shanghai Haishun New Pharmaceutical Packaging Materials Co., Ltd.'s Deposit of Raised Funds in Agreement Deposits
CITIC Securities Co., Ltd. Verification Opinion on Shanghai Haishun New Pharmaceutical Packaging Materials Co., Ltd.'s Use of Part of Idle Raised Funds to Temporarily Supplement Working Capital
Announcement on Using Part of Idle Raised Funds to Temporarily Supplement Working Capital
Notice of Convening the 2025 Annual General Meeting of Shareholders
Announcement of Resolutions of the Fourth Meeting of the Sixth Board of Directors
Resolutions of the First Special Meeting of Independent Directors of the Sixth Board of Directors in 2026
Announcement on the 2025 Annual Profit Distribution Plan
Special Report on the Deposit and Use of Raised Funds for the Year
Special Report on Securities Investment for 2025
CITIC Securities Co., Ltd. Verification Opinion on Shanghai Haishun New Pharmaceutical Packaging Materials Co., Ltd.'s Use and Deposit of Raised Funds for 2025
Shanghai Haishun New Pharmaceutical Packaging Materials Co., Ltd. 2025 Annual Attestation Report on the Deposit, Management, and Use of Raised Funds
Special Verification Opinion on the Deduction of Operating Revenue
Assessment Report on the Accounting Firm's Performance
Report of the Board of Directors' Audit Committee on the Assessment of the Accounting Firm's Performance in 2025 and the Fulfillment of its Supervisory Responsibilities
Special Audit Explanation on Shanghai Haishun New Pharmaceutical Packaging Materials Co., Ltd.'s 2025 Non-Operating Fund Occupancy and Other Related Fund Transactions
Summary Table of Non-Recurring Fund Occupancy and Other Related Fund Transactions
Special Assessment Opinion of the Board of Directors on the Independence of Independent Directors
2025 Annual Audit Report
2025 Annual Report
2025 Annual Report Summary
Announcement on the 2026 Interest Payment of Convertible Corporate Bonds
Announcement on Returning Idle Raised Funds Temporarily Used to Supplement Working Capital
Notes & Comments
Sign in to leave a comment or private note.
Loading…